H.C. Wainwright Adjusts BioXcel Therapeutics, Inc. (BTAI) Outlook Following Capital Structure Concerns
We recently compiled a list of the 10 Best Beaten Down Stocks to Invest in According to Analysts. BioXcel Therapeutics, Inc. is one of the best 52-week low stocks. TheFly reported on April 2 that H.C. Wainwright lowered its price target on BTAI to $5 from $6 while maintaining a Buy rating. The firm attributed the revision to concerns over recent and expected equity dilution, which influenced its updated valuation outlook. Separately, on April 8, BioXcel Therapeutics, Inc. (NASDAQ:BTAI) announced that it ...